PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response

Oncotarget
Stephanie WursterKerstin Borgmann

Abstract

There is a need to develop new, more efficient therapies for head and neck cancer (HNSCC) patients. It is currently unclear whether defects in DNA repair genes play a role in HNSCCs' resistance to therapy. PARP1 inhibitors (PARPi) were found to be "synthetic lethal" in cancers deficient in BRCA1/2 with impaired homologous recombination. Since tumors rarely have these particular mutations, there is considerable interest in finding alternative determinants of PARPi sensitivity. Effectiveness of combined irradiation and PARPi olaparib was evaluated in ten HNSCC cell lines, subdivided into HR-proficient and HR-deficient cell lines using a GFP-based reporter assay. Both groups were equally sensitive to PARPi alone. Combined treatment revealed stronger synergistic interactions in the HR-deficient group. Because HR is mainly active in S-Phase, replication processes were analyzed. A stronger impact of treatment on replication processes (p = 0.04) and an increased number of radial chromosomes (p = 0.003) were observed in the HR-deficient group. We could show that radiosensitization by inhibition of PARP1 strongly correlates with HR competence in a replication-dependent manner. Our observations indicate that PARP1 inhibitors are promisin...Continue Reading

References

Jan 15, 2003·Archives of Otolaryngology--head & Neck Surgery·David I KutlerBhuvanesh Singh
May 4, 2005·Cellular and Molecular Life Sciences : CMLS·E PetermannS L Oei
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey M AlbertBo Lu
Oct 29, 2008·International Journal of Radiation Oncology, Biology, Physics·Fiona A DungeyAnthony J Chalmers
Nov 26, 2008·Seminars in Radiation Oncology·Quynh-Thu Le, David Raben
Oct 23, 2009·Nature·Stephen P Jackson, Jiri Bartek
Sep 14, 2010·Seminars in Radiation Oncology·Anthony J ChalmersRobert G Bristow
Mar 25, 2011·Nature Reviews. Cancer·Adrian C BeggConchita Vens
Oct 6, 2011·Molecular Cancer Therapeutics·Joana M SenraIan J Stratford
Feb 14, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ann Christin ParplysKerstin Borgmann
May 11, 2012·Nucleic Acids Research·Brian BudkePhilip P Connell
Oct 25, 2013·Nature Communications·Jenni NikkiläRobert Winqvist
Jun 26, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kishan A T NaipalDik C van Gent
Sep 24, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·George D WilsonJiayi Huang
Oct 8, 2014·DNA Repair·Ann C ParplysClaudia Wiese
Nov 18, 2014·Nature Communications·Shailja PathaniaDavid M Livingston
Dec 4, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Julian David GüsterThorsten Rieckmann
May 20, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Caroline V M VerhagenConchita Vens
Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Linda HennemanJos Jonkers

❮ Previous
Next ❯

Citations

Jul 10, 2019·International Journal of Cancer. Journal International Du Cancer·Rüveyda DokSandra Nuyts
Jan 21, 2020·Journal of Cellular and Molecular Medicine·Chuan LiuGuohua Hu
Jul 3, 2020·Expert Reviews in Molecular Medicine·Chumin Zhou, Jason L Parsons
Aug 19, 2017·Cancer Metastasis Reviews·Masashi YamamotoTakashi Nakagawa
Aug 8, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sana D KaramDavid Raben
Aug 16, 2019·Molecular Cancer Therapeutics·Anna R MichmerhuizenCorey Speers
Sep 2, 2019·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C HennequinL Quero
Dec 3, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rosemarie de HaanBaukelien van Triest

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
chromosomal aberrations
xenografts
biopsies
X-ray
flow cytometry
fluorescence microscopy

Software Mentioned

ModFitLT
GraphPad
Prism
ImageJ
Axiovision

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2022 Meta ULC. All rights reserved